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Understanding the
epidemic of HIV in South
Africa
Analysis of the antenatal clinic survey
data
Brian Williams, Catherine Campbell
Objectives. To investigate the magnitude and the time
course of the HIV epidemic in the provinces of South
Africa from the antenatal clinic HIV surveys.
Design. We analysed the data on the provincial
prevalences of HIV infection from 1990 to 1996 using
maximum likelihood methods to determine the intrinsic
growth rate and probable asymptotic prevalence of HIV
among women attending antenatal clinics.
Subjects: Women attending antenatal clinics and
included in the national HIV prevalence surveys conducted
by the Department of Health.
Results. 1; In Kwazulu-Natal the epidemic is likely to
peak at a prevalence of about 23% (95% confidence
interval (Cl) 19 - 36%). 2. The intrinsic doubling time does
not differ significantly among the provinces. 3. The average
length of the intrinsic doubling time is 12.0 months (95% Cl
11.3 - 12.8 months). 4. The force of infection is
approximately 1.OO/year at age 16 years and declines at a
rate of about 5% per year of age above 16 years.
Conclusions. South Africa is likely to experience one of
the worst HIV epidemics in Africa. The lack of statistically
significant differences between the growth rates of the
epidemic in the various provinces constrains the possible
explanations that can be advanced to explain the time
course of the epidemic and may in part be a consequence
of migrancy. The intrinsic growth rate is higher than
previous estimates and it is possible that in those
provinces where the prevalence is still low it will eventually
reach the same levels as in Kwazulu-Natal.
S Atr Med J 1998; 88: 247-251.
The data collected by the Department of Health through
their annual antenatal clinic surveys represent the most
important source of information on HIV in South Africa.
These are the only data that provide any indication of the
time course and geographical spread of the epidemic in this
country.l,2 The importance of these data cannot be
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overstated, but it is essential to analyse them carefully if
reliable conclusions are to be drawn about the past and
probable future time course of the epidemic. We use the
data to estimate the likely asymptotic prevalence, the
intrinsic growth rate of the epidemic in different provinces
and the age-dependent force of infection. The asymptotic
prevalence gives a measure of the probable long-term
burden of disease. The intrinsic growth rate indicates the
rate at which the infection is increasing and provincial
estimates will partly determine explanations of the spread of
the epidemic. The age-dependent force of infection
indicates how the risk of infection varies across age groups.
When serious attempts to manage the epidemic are made,
these data and the parameters derived will provide essential
baseline information against which to assess the
effectiveness or otherwise of disease management
programmes.
The dataset
The data are taken from the results of the national HIV
surveys.1.2 These give, by province, the number of women
tested and the proportion who are HIV-positive each year
from 1990 to 1996. Two limitations of these data for making
predictions are immediately evident. Firstly, for each
province there are only seven data points, a feature that
limits the precision with which model parameters can be
estimated, and secondly in some of the prOVincial surveys,
especially in the earlier surveys, only 1 or 2 people were
positive, which results in very large error margins on some of
these data points.
The logistic model
The 1996 survey gives, for the first time, evidence of a
decline in the growth rate of the epidemic. We have
therefore chosen to fit the data to logistic curves from which
the intrinsic growth rate of the epidemic (the rate of increase
in prevalence when the prevalence is still very low) and of
the asymptotic prevalence (the prevalence at which the
epidemic will level off) can be estimated. To fit the data we
have used maximum likelihood estimation procedures,'
which give minimum variance estimators for the parameters
and, in particular, allow the use of exact binomial error




Each of the provincial datasets was fitted to the logistic
model given in Appendix 1 and the resulting asymptotic
values are shown in Fig. 1. (Details of the calculation of the
error limits are given in Appendix 2.) From Fig. 1 it is clear
that the epidemic is SUfficiently advanced to obtain useful
estimates of the asymptotic prevalence only in Kwazulu-
Natal and Mpumalanga. For Kwazulu-Natal the best fit value
is 23.4% (18.7 - 35.6%, 95% confidence interval (Cl) here
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and elsewhere). For Mpumalanga the estimated asymptote
is 19.6% (16.1 - 26.9%). Apart from Northern Province, for
which the data are problematic, as discussed below, there
are no significant differences between provinces and we
have set the asymptotic prevalence at 26.8% in the
following analyses. This is consistent with rates in other
countries in the region where, for example, the antenatal
prevalence in 1995 "'fas 29% in Gaborone, Botswana, 19%
in Swaziland and 32% in Harare, Zimbabwe (US Bureau of
Census, Population Division, International Programmes
Center, HIV/AIDS Surveillance Database, June 1996).
different provinces is surprising, as one might expect the
epidemic pattern to vary between places with different
socio-economic conditions. In the Western Cape, however,
where the prevalence is low and few people in the sample
have tested positive, the error bars on the data (Fig. 2) are
correspondingly large and the estimate of the doubling time
correspondingly poor; future data might well show that the
epidemic is increasing more slowly in the Western Cape
than elsewhere. On the basis of the available data the most
parsimonious assumption is that the epidemics are following
essentially the same time course but lagging behind
KwaZulu-Natal.
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Fig. 1. The asymptotic prevalence of HIV infection in the various
provinces. EC: Eastern Cape, 11 % (7% - 77%); FS: Free State,
30% (17% - 100%); GT: GajJteng, 78% (26% - 100%); KN:
KwaZulu-Natal, 23%119% - 26%); MP: Mpumalanga, 20% (16% -
27%); NW: North-West, 100% (> 43%); NC: Northern Cape, 11 %
(5% - 100%); NP: Northern Province, 17% (6% - 100%); WC:
Western Cape, 2.4% (1.3% - 100%). The error bars give 95%
confidence limits. The horizontal line is the value used in
subsequent calculations.







1990 1992 1994 1996 1990 1992 1994 1996
Year Year
-20 Gauren9 ~20;,'i KwaZululNatal
-;15 815u
a; 10 .£j 10ro '"> 5 > 5l':' l':'
Q. 0 D- O







> 2Cl)• ci: 00
















Estimating the intrinsic rate of
increase (doubling time)
It has become something of a received truth in South
African HIV/AIDS circles that the epidemic is progressing
faster in some provinces, e.g. KwaZulu-Natal, than in others,
e.g. Western Cape. Do the data support this assumption?
Having fixed the asymptotic prevalence to 26.8% in all
provinces, logistic curves were then re-fitted to each
provincial dataset with the results shown in Fig. 2.
With the exception of Mpumalanga and North-West, the
fits are acceptably good in all cases. In Mpumalanga the
data seem unreliable as they imply that there was no
significant increase in prevalence from 1992 to 1993
followed by a fivefold increase in 1994. In North-West, the
prevalence for 1991 would appear to be in error and while
the increase from 1994 to 1995 was marginal and not
statistically significant, there appears to have been an
almost threefold increase in 1996. It would seem likely that
the 1995 value is incorrect.
From the fits given in Fig. 2, the intrinsic rate of increase
can be estimated (f in equation 1, Appendix 1) and the initial
doubling times for the epidemic in each province can be
estimated as shown in Fig. 3. None of the doubling times
differs significantly from the mean value, which is 12.0
months (11.3 - 12.8 months). The fact that there are no
significant differences among the dOUbling times in the
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Fig. 2. Logistic curves fitled to the provincial antenatal clinic data
with the asymptotes set to 26.8%.
In order to determine the time lag between the epidemics
in the various provinces we set the intrinsic growth rate for
each province to the average value for all the provinces
(0.691 ± 0.066 per year), keeping the asymptotic prevalence
at the previous value of 26.8%; we then fitted each
provincial dataset to logistic curves. The results in Fig. 4
show that Mpumalanga, Free State, North-West and
Gauteng all follow the epidemic in KwaZulu-Natal by about 1
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year, the Eastern Cape, Northern Province and the Northern
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Fig. 3. Doubling times for the prevalence of HIV based on the
intrinsic rate of increase in the various provinces obtained by
fitting logistic curves to the provincial prevalences with the
asymptote set to 26.8%. EC: 13.6 months (11.7 - 16.4 months); FS:
11.9 months (10.0 - 14.7 months); GT: 11.3 months (10.0 - 12.9
months); KN: 11.7 months (10.2 - 13.8 months); MP: 10.0 months
(8.7 - 11.8 months); NW: 12.1 months (9.2 - 17.6 months); NC: 14.3
months (11.6 - 18.8 months); NP: 10.4 months (8.0 - 14.7 months);





























Fig. 5. The national age prevalence for HIV infection from the
antenatal clinic data fitted to the model given in Appendix 3
(upper curve 1995, lower curve 1996).
Fig. 4. The time lag in years between the epidemics in the various
provinces if it is assumed that the asymptotic value is 26.8% and
the intrinsic growth rate is 0.691 per year in all cases.
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Estimating the force of
infection
The best fits to the data are obtained if we assume that
sexual activity first takes place at 16 years of age. The
estimates of the force of infection are then 1.05 ± 0.20 per
year for 1995 and 0.91 ± 0.20 per year for 1996 at age 16,
and the estimates of the rate at which the force of infection
decreases with age are 5.8 ± 1.9% per year for 1995 and
3.8 ± 1.9% per year for 1996. In fact it is likely that some
people engage in sexual activity before the age of 16 and
that the risk of infection increases with age to some
maximum value, after which it declines. The present data do
not warrant the use of more sophisticated models. The
important point is that if sexual activity does not decline with
age, the decline in prevalence with age cannot be
reproduced; however, the rate at which prevalence declines
with age also depends on the rate at which the epidemic
increases. In essence the prevalence among people who are
now aged 50, say, is low both because the likelihood of their
now engaging in high-risk sexual activities is less than it is
for the younger age groups, and because when they were
younger the prevalence was lower, which consequently
lowered their risk. Based on the available data, at the end of
1996 a 16-year-old in KwaZulu-Natal had an annual risk of
becoming infected of about 20%, while for a 46-year-old the
annual risk was about 4%. In the Western Cape the
corresponding risks were about 2% and 0.4%.
This analysis of the provincial data for the prevalence of HIV
infection among women attending antenatal clinics indicates














Using the age distribution of prevalence, it is possible to
estimate the force of infection (A) which, when multiplied by
the prevalence, gives the rate at which those susceptible
become infected. The model, given in Appendix 3, assumes
that the force of infection is proportional to the overall
prevalence at any time but declines exponentially with age.
Unfortunately the numbers of people in each age group who
were tested in each province are too small to estimate the
force of infection for each province separately, and we have
therefore fitted the model to the national age prevalence
data for 1995 and 1996 (Fig. 5).
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in Kwazulu-Natal is 24%. Reasonably precise estimates of
the prevalence can only be obtained for Kwazulu-Natal,
because the data for North-West and Mpumalanga are
problematic and the epidemics in the other provinces are
not sufficiently advanced. However, the data for all of the
provinces are consistent with an asymptotic prevalence of
27% and this is similar to values that have already been
observed in other cities and countries in southern Africa
(US Bureau of Census, Population Division, International
Programmes Center, HIVlAIDS Surveillance Database, June
1996). It should be noted, however, that more detailed
models' generally show that the prevalence initially
increases exponentially, peaks as the number of remaining
susceptible individuals declines, and then falls by up to
10 - 20% as those with HIV infection succumb to AIDS and
AIDS-related diseases. We do not yet have sufficient data to
test these more sophisticated models rigorously. If the
nationwide prevalence among women attending antenatal
clinics does reach this level, the number of HIV-infected
people could reach approXimately 4.5 million, which implies
that as the epidemic matures there could be between
500000 and 1 million deaths a year from AIDS and AIDS-
related disease. This will place a substantial burden on
caregivers and the health services generally and plans must
be implemented as a matter of urgency to deal with this.
Furthermore, relatively few data are available on the burden
and clinical spectrum of AIDS-related disease among
various groups of people in South Africa, without which it is
almost impossible for the health services to plan ways in
which to deal with the consequences of the epidemic.
The lack of significant differences among the intrinsic
epidemic growth rates in the various provinces is surprising,
although the data do not rule out the possibility that more
extensive data collected in future surveys will reveal such
differences. The very high levels of migrancy in South Africa
must be .important in determining the patterns of disease
transmission, but these have received very little attention.
A possible explanation for the similarity between the
doubling times in the various provinces is that the effect of
migrancy between provinces is to lock the epidemics
together, so that the epidemic in the low-prevalence areas is
effectively driven by the epidemic in the high-prevalence
areas. Consider, for example, two areas, in the first of which
the doubling time is 1 year and in the second of which it is 2
years. If it is assumed that 10% of the people in each area
move to the other area each year the epidemic growth rate
in the first area falls slightly and in the second area
increases rapidly to match that in the first area.5 Much more
extensive models of the geographical distribution and
spread of HIV are needed to elucidate this, and the
antenatal clinic data which are now available for each health
district in the country will prOVide an important starting point
for such analyses.
The estimates of the force of infection are still speculative,
given that the extent of the data is insufficient to provide
precise estimates. However, the available estimates and, in
particular, the way in which they vary with age, provide an
important starting point for modelling the impact that the
epidemic is likely to have on different age groups and this
will be essential both for deciding on how best to target
intervention programmes and for reliable estimation of the
likely social and economic impacts of the epidemic.
Having done little to stem the rising tide of the epidemic
over the last 7 years, we now read that 'with HIV infection
already so high ... some activists say "we missed the boat"
on prevention and that resources should now be focused on
providing the best possible care'" The increase in the care
needs of people with AIDS and AIDS-related diseases will
undoubtedly lead the health services to change the way in
which resources are allocated and patients are dealt with.
But it is important to stress that even though the prevalence
in Kwazulu-Natal and some other provinces may be
approaching their peak levels, currently uninfected people
will still become infected while some of those who are
already infected will die, and a reduction in the force of
infection will still prevent many future deaths.
While the antenatal clinic data are of great importance in
providing information about the present state and probable
future spread of the epidemic, it is remarkable that they are
still virtually the only useful data available. Resources should
be committed to the supplementation of these data with
much more detailed studies at sentinel sites, which should
be chosen to be representative of different socio-economic
situations in the country. These sentinel sites should be used
to monitor not only HIV but other sexually transmitted
diseases that enhance the spread of HIV, and they should be
used to collect socio-economic and behavioural data,
especially those on sexual networking patterns; this
information should be linked to the biomedical data. Such
data are now being collected in Hlabisa. Furthermore, a
group representing a range of stakeholders including three
mining houses, the trade unions and the Department of
Health, as well as research institutes and non-government
organisations, is planning a major intervention to improve
the management of STDs and to promote community
outreach and condom distribution in Carletonville. This
intervention will be carefully monitored and evaluated using
biomedical measures of STD incidence and HIV prevalence
as well as social measures of behaviour, knowledge and
attitudes towards HIV and STDs. Biomedical and
behavioural surveys will be carried out at the beginning and
at the end of the project and, during the course of the
project, extensive in-depth interviews and focus group
discussions will be held with those liVing and working on the
mines as well as the people in the Carletonville community.
It is hoped that such studies will supplement the few data
that are currently available and provide an important
contribution to the management of HIV and STDs in other
settings.
Appendix 1. With a logistic model, p(t), the prevalence of
infection at time t may be written
Px POer(t - tal
P = --------,-,----,-,
(poc - po) + poer(t - tal
where Px is the eventual asymptotic prevalence, Po is the
prevalence at time to, and r is the intrinsic growth rate. In
the early stages the prevalence increases exponentially at
a rate r and then converges exponentially to Px, also at a
rate r.
Appendix 2. When the error limits on the estimates are
calculated, the three parameters Px, Po and r are closely
correlated. Furthermore, PO' in particular, is bound from
below at 0, while the coefficient of variation is, in many
cases, close to 1. The standard error analysis using
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maximum likelihood techniques assumes that the likelihood
function is Gaussian while in these analyses the likelihood
function, and the consequent error limits, are highly
asymmetrical. In order to estimate the upper and lower
confidence limits on the asymptotic prevalence it is therefore
necessary to vary the asymptote, maximise the likelihood
function by varying the other two parameters, Po and (, and
use a likelihood ratio test to find critical values
corresponding to upper and lower bounds for 95%
confidence limits.
Appendix 3. In order to obtain a functional form for the
age-prevalence data, we note that the probability that a
susceptible individual becomes infected at any time is
proportional to the force of infection, A, multiplied by the
overall population prevalence. Consider then a person
whose age is a1 at time t1 . The probability that this person
would have been infected at age a (assuming they were not
already infected) is
p(a) = AP (t1 - a1 + a) =Acer{t1- a1 + a)
where pet) is the prevalence at time t, and c and ( are
chosen to match the change in overall prevalence with time.
If we also let sexual activity decline exponentially from 1 at
age aO at a rate s, equation 2 becomes
p(a) = AP (t - a1- ale -5(a - aol·
Then, counting in time increments of 8t, the probability of
not being infected between ages aO and a" is:
q = (1 - Acii 8t)(1 - Acerte{r - 5)8t 8t) ...(1 _ Acert"""e{r - s)(a1 - ao)8t)
where t = t - (a1 - aO)' so that
In(q) =-Acert 8t(1 + e{r- 5)8t +...+ e(r- s){a1 - ao).
Summing the series gives
In(q) = Acert (1 - e(r - s){a1 - aO)/(( - s)
and the probability that an individual of age a is infected at
time t is p = 1 - q.
More sophisticated models would use a logistic form for
the time dependence of the prevalence and include the
distribution of the relative ages of sexual partners. However,
the present data fit this simple model reasonably well and
do not warrant the use of more extensive models.
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A pharmaco-economic study based on a
meta-analysis
Fran'rois Wessels, A Nixon Anderson,
Osman Ebrahim
Objectives. A retrospective analysis was conducted to
assess the cost-effectiveness of four intravenous
antibiotic treatment regimens in the treatment of severe
community-acquired pneumonia (CAP) in adults in a
private hospital setting. The study compared some third-
generation cephalosporin regimens with a second-
generation cephalosporin and an amoxicillin/clavulanic
acid (co-amoxiclav) regimen to investigate published
South African treatment guidelines from a pharmaco-
economic point of view.
Method. A phanmaco-economic model of local costs,
from a payer perspective, was based on the results of a
meta-analysis of clinical papers from peer-reviewed
journals. The study compared intravenous (IV) ceftriaxone
(2 g once daily), cefotaxime (IV 2 g 3 times a day),
cefuroxime (IV 750 mg 3 times a day, followed by 500 mg
orally 3 times a day) and amoxicillin/c1avulanic acid
(IV 750 mg 3 times a day, followed by 625 mg orally 3
times a day).
Results. An analysis of the odds ratios (ORs) of all two-
way comparisons indicated that ceftriaxone ensured
significantly higher probabilities of successful outcomes
than the other antibiotic treatment regimens (ORs in the
order of two were indicated). The phanmaco-economic
results suggested that the ceftriaxone treatment regimen
was the most cost-effective in the hospital treatment of
CAP in adult patients. These results proved to be robust
across sensitivitj analyses for success rates and
treatment days. A sensitivity analysis testing the
assumption that patients could be discharged once the
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